Search results
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 7 days agoPfizer also recently said its new drug, Adcetris, improved overall survival, progression-free ...
Lung Cancer Was a Death Sentence. Now Drugs Are Saving Lives.
The Wall Street Journal· 3 days agoMore patients can fend off the disease for months or years with targeted or immune-boosting drugs,...
Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib(ROS1 Inhibitor) are...
The Grass Valley Union· 4 days agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the ...
CARVYKTI® (ciltacabtagene autoleucel) significantly improved progression-free survival and deepened...
Forrest City Times-Herald· 2 days agoJohnson & Johnson announced today results from a subgroup analysis of the Phase 3 CARTITUDE-4 study. Data from the CARTITUDE-4 study supported the recent U.S. FDA approval of CARVYKTI®, the ...
G1 Therapeutics seeks partner to advance cancer treatment - Triangle Business Journal
The Business Journals· 6 days agoA biopharmaceutical company in Research Triangle Park is looking for a partner to advance one of its...
Gilead’s Trodelvy misses goal in bladder cancer study
BioPharma Dive via Yahoo Finance· 5 days agoTreatment didn’t significantly improve overall survival in the trial, a finding that one analyst...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 2 days agoThe vaccine together with Merck's Keytruda improved survival and showed long-lasting efficacy in a...
Gilead’s Phase III urothelial cancer trial fails to meet primary endpoint
Clinical Trials Arena via Yahoo Finance· 5 days agoThe study also indicated trends towards better outcomes in progression-free survival and overall...
Gena McCarthy’s UNConventional Entertainment Signs With Buchwald
Deadline via Yahoo News· 2 days agoEXCLUSIVE: Gena McCarthy and her UNConventional Entertainment banner has new representation. The ...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
NBC New York· 2 days agoModerna and Merck said their experimental vaccine in combination with the therapy Keytruda improved survival and showed durable efficacy in a midstage study in patients with ...